Considering that HCC is a malignant tumor rich in microvessels and that the VEGFA signaling pathway plays a key role, we hypothesized that ASH2L‐lys312 lactylation enhances angiogenesis, thereby facilitating HCC malignant progression. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.